Extension Study of Iron Chelation Therapy With Deferasirox in Patients With Transfusional Iron Overload

Clinical trial NCT00379483 · COMPLETED

Trial details

NCT number: NCT00379483
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Transfusional Iron Overload

Start date: 2002-07-01
Primary completion: 2003-04-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.